共查询到16条相似文献，搜索用时 203 毫秒
1.
《动物医学进展》2015,(8)
为研究制何首乌水提液对小鼠成骨细胞MC3T3-E1的影响,将不同浓度的制何首乌水提液作用于MC3T3-E1细胞,采用噻唑蓝(MTT)法、碱性磷酸酶(ALP)活力检测试剂盒和实时荧光定量PCR法对细胞增殖、ALP蛋白分泌及骨保护素(OPG)和核因子κB受体活化因子配体(RANKL)mRNA表达水平进行检测。结果显示,药物作用2d和3d后,各浓度制何首乌水提液均可促进MC3T3-E1细胞增殖;药物作用6d后,各浓度制何首乌水提液均可促进MC3T3-E1细胞分泌ALP;药物作用1d后,较高浓度制何首乌水提液可上调MC3T3-E1细胞OPG/RANKL mRNA表达比。表明制何首乌水提液具有促进成骨细胞增殖、分化和上调成骨细胞OPG/RANKL mRNA表达比的作用。 相似文献
2.
通过探讨骨碎补水提液对大鼠成骨细胞中OPG mRNA水平表达的影响,来研究骨碎补对成骨细胞产生作用的分子机制。细胞培养48h后,应用荧光定量RT-PCR方法检测不同浓度骨碎补水提液及雌激素受体抑制剂ICI 182780作用后,细胞中OPG mRNA水平表达的变化。结果显示,骨碎补水提液作用于大鼠成骨细胞48h后,与对照组相比,高浓度骨碎补水提液显著上调OPG mRNA的比值,而低浓度组与对照组无显著差异。加入雌激素受体抑制剂ICI 182780后,骨碎补对OPG mRNA水平的促进作用消失。表明骨碎补水提液能上调OPG mRNA水平的表达,且呈剂量依赖性。上述促进作用能被雌激素受体抑制剂阻断,因而可以推测这个过程与雌激素受体通路有关。 相似文献
3.
骨碎补水提液对大鼠成骨细胞的影响 总被引：1，自引：0，他引：1
为观察骨碎补水提液对体外培养大鼠成骨细胞增殖、分化的影响,用体外培养新生SD大鼠颅盖骨分离的成骨细胞,将不同浓度的骨碎补水提液分别与第3代大鼠成骨细胞进行体外共同培养,采用噻唑蓝(MTT)法测定细胞增殖能力,对硝基苯磷酸盐法(PNPP法)测定细胞的碱性磷酸酶(ALP)活性.结果显示,与对照组相比,作用48 h、72 h,骨碎补水提液均能显著促进大鼠成骨细胞的增殖,且与时效有关;作用48 h ,10-3、10-2 mg/mL骨碎补水提液浓度组可显著升高细胞ALP活性(P<0.05).表明骨碎补水提液中存在较高活性的促大鼠成骨细胞增殖和分化的物质. 相似文献
4.
为了观察氟对体外培养的小鼠成骨细胞中OPG/RANKL mRNA表达的影响,取30只出生24 h以内的昆明小鼠,无菌条件下取其头盖骨,去除筋膜和结缔组织,用胰蛋白酶-胶原酶消化法进行原代成骨细胞的培养。取其第2代成骨细胞,分成试验组和对照组,试验组培养液中分别加入不同浓度的氟化钠（10^-12、10^-11、10^-10、10^-9、10^-8mol/L）,培养40 h,收集细胞板中贴壁的细胞提取总RNA,采用荧光定量RT-PCR法检测细胞中OPG/RANKL mRNA的变化。结果试验组中OPG/RANKL mRNA的比值显著升高,且随着氟化钠浓度的增加先升高,后降低,10^-10mol/L氟化钠达到最大值（P〈0.01）。说明微量氟可以减少破骨细胞的成熟分化,使骨吸收能力减弱,相应地增加了骨形成的过程。 相似文献
5.
6.
为了探讨松果菊苷对体外培养大鼠成骨细胞骨桥素(OPN)mRNA和蛋白质表达的影响,选取出生24 h内的SD大鼠颅盖骨,依次用胰酶和胶原酶消化分离培养成骨细胞,用不同浓度的松果菊苷作用于第3代细胞,选取雌二醇为阳性对照,分别在药物作用24、48和72 h后提取细胞总RNA的表达量,用荧光定量PCR(FQ-PCR)法检测细胞中OPN mRNA的表达量;用Western blotting检测细胞中OPN蛋白的表达量。结果显示,各浓度松果菊苷在各个时间段均增加OPN基因的表达,尤其是5×10-5和5×10-6 mg/mL松果菊苷在各时间段均具有显著或极显著地促进作用(P＜0.05或P＜0.01);各浓度组在作用48 h时蛋白质的表达量均高于对照组。结果表明,松果菊苷对成骨细胞OPN基因表达有显著的促进作用,同时对OPN蛋白的分泌有促进的趋势。 相似文献
7.
《黑龙江畜牧兽医》2010,(21)
为了研究胰岛素样生长因子-1(insulin-like growth factor,IGF-1)对奶牛成骨细胞骨重建相关因子表达的影响,探讨IGF-1对奶牛成骨细胞形成-吸收的作用,试验采用体外分离培养奶牛成骨细胞,用改良Gomori钙钴法染色鉴定,再以0,1,10,50,100 ng/mL人重组胰岛素样生长因子-1(recombinated human insulin-like growth factor-1,rhIGF-1)干预培养5 d后,半定量RT-PCR法检测成骨细胞骨保护素(osteoprotegerin,OPG)和核因子κB受体活化因子配体(receptor activator of nu-clear factor-κB ligand,RANKL)mRNA的表达,ELISA检测细胞培养上清液OPG蛋白水平。结果表明:1~100 ng/mL rhIGF-1干预5 d,OPG、RNAKL mRNA表达均较未干预组增加,10,50,100 ng/mL组OPG/β-actin、RANKL/β-actin比值显著高于未干预组(P0.05),且在1~100 ng/mL浓度范围内,rhIGF-1呈剂量依赖方式上调OPG蛋白表达,其中10,50,100 ng/mL干预组与未干预组差异显著(P0.05)。说明IGF-1调控奶牛成骨-破骨细胞介导的形成-吸收偶联,促进骨形成,这可能是IGF-1参与奶牛骨代谢性疾病的重要机制之一。 相似文献
8.
为探索二苯乙烯苷(THSG)保护成骨细胞抗氧化损伤的作用机制，本试验使用不同浓度THSG预处理MC3T3-E1成骨样细胞1 h,加入0.3 mmol/L过氧化氢(H2O2)共同培养细胞，采用噻唑蓝(MTT)法检测细胞生存活力；实时荧光定量聚合酶链式反应(FQ-PCR)法检测细胞Bcl-xL/Bcl-2相关死亡启动因子(Bad)、骨保护素(OPG)、核因子κB受体活化因子配体(RANKL)和β-连环蛋白(β-catenin)mRNA表达水平；Western blot法检测细胞OPG和β-catenin蛋白水平。结果显示，与对照组相比，H2O2组细胞生存活力显著下降(P<0.05),Bad和RANKL mRNA表达水平显著上升(P<0.05),OPG和β-catenin mRNA和蛋白水平均显著下降(P<0.05);与H2O2组相比，THSG(10-4mg/mL)保护组细胞生存活力显著上升(P<0.05),Bad和... 相似文献
9.
补骨脂水提液及补骨脂素对体外培养成骨细胞的影响 总被引：1，自引：0，他引：1
为了探讨补骨脂水提液及补骨脂素对体外培养成骨细胞的影响,采用MTT法、PNPP(对硝基苯磷酸二钠盐)法及流式细胞术,分别检测不同浓度的补骨脂水提液(10-4～101 mol·L-1)及补骨脂素(10-8～10-4mol·L-1)对体外培养小鼠成骨细胞增殖、分化及细胞周期的影响.结果表明,10、10-8 mg·ml1补骨脂水提液对成骨细胞有明显的促增殖作用;高浓度(10-4、10-5 mol·L-1)补骨脂素抑制细胞增殖,而低浓度(10-7、10-8mol·L-1)补骨脂素能够促进增殖;10-4、10-6 、10-8 mol·L-1补骨脂素均能使成骨细胞碱性磷酸酶(ALP)活性明显上升;各浓度的补骨脂水提液及补骨脂素使细胞G1期百分比降低,而S期、G2期百分比显著增加.试验结果证实补骨脂水提液及补骨脂素具有植物雌激素样作用,可以促进成骨细胞增殖,促使细胞由G1期向S期、G2期转化;补骨脂素是促进成骨细胞分化的有效成分. 相似文献
10.
骨是镉毒性作用的主要靶器官之一,但其对鸡骨髓基质细胞(bone marrow stromal cells,BMSCs)增殖和成骨分化的毒性作用仍不清楚。本研究利用差速贴壁纯化法获得鸡BMSCs,加入不同浓度镉处理不同时间,采用CCK-8法检测细胞增殖,碱性磷酸酶(alkaline phosphatase,ALP)和茜素红染色鉴定成骨分化,RT-PCR检测成骨相关基因(COL1、OSX、RUNX2、ALP、OCN、OPG、OPN、RANKL)表达变化。结果显示,1~10μmol/L的镉显著促进BMSCs增殖,20μmol/L的镉显著抑制其增殖(P<0.05);5μmol/L以上的镉可显著抑制ALP活性,并以浓度依赖方式极显著抑制成骨相关基因(COL1、OSX、RUNX2、ALP、OCN、OPG、OPN)mRNA表达,上调RANKL mRNA表达(P<0.01)。表明,一定浓度镉可抑制鸡BMSCs体外增殖及其向成骨细胞(OB)的分化。 相似文献
11.
Immunohistochemical Localization of RANK, RANKL and OPG in Healthy and Arthritic Canine Elbow Joints
ANDREA I. SPAHNI Dr. med. vet. PETER SCHAWALDER Prof. Dr. med. vet. BARBARA ROTHEN PD Dr. sc. nat. ETH DIETER D. BOSSHARDT PD Dr. sc. nat. PhD NIKLAUS LANG Prof. Dr. med. dent. MICHAEL H. STOFFEL Prof. Dr. med. vet. 《Veterinary surgery : VS》2009,38(6):780-786
Objective— To determine if the receptor activator of nuclear factor-κB–receptor activator of nuclear factor-κB ligand–osteoprotegerin (RANK–RANKL–OPG) system is active in bone remodeling in dogs and, if so, whether differences in expression of these mediators occur in healthy and arthritic joints.
Study Design— Experimental study.
Sample Population— Fragmented processus coronoidei (n=20) were surgically removed from dogs with elbow arthritis and 5 corresponding healthy samples from dogs euthanatized for reasons other than elbow joint disease.
Methods— Bright-field immunohistochemistry and high-resolution fluorescence microscopy were used to investigate the distribution of RANK, RANKL, and OPG in healthy and arthritic joints.
Results— All 3 molecules were identified by immunostaining of canine bone tissue. In elbow dysplasia, the number of RANK-positive osteoclasts was increased. In their vicinity, cells expressing RANKL, a mediator of osteoclast activation, were abundant whereas the number of osteoblasts having the potential to limit osteoclastogenesis and bone resorption via OPG was few.
Conclusions— The RANK–RANKL–OPG system is active in bone remodeling in dogs. In elbow dysplasia, a surplus of molecules promoting osteoclastogenesis was evident and is indicative of an imbalance between the mediators regulating bone resorption and bone formation. Both OPG and neutralizing antibodies against RANKL have the potential to counterbalance bone resorption.
Clinical Relevance— Therapeutic use of neutralizing antibodies against RANKL to inhibit osteoclast activation warrants further investigation. 相似文献
Study Design— Experimental study.
Sample Population— Fragmented processus coronoidei (n=20) were surgically removed from dogs with elbow arthritis and 5 corresponding healthy samples from dogs euthanatized for reasons other than elbow joint disease.
Methods— Bright-field immunohistochemistry and high-resolution fluorescence microscopy were used to investigate the distribution of RANK, RANKL, and OPG in healthy and arthritic joints.
Results— All 3 molecules were identified by immunostaining of canine bone tissue. In elbow dysplasia, the number of RANK-positive osteoclasts was increased. In their vicinity, cells expressing RANKL, a mediator of osteoclast activation, were abundant whereas the number of osteoblasts having the potential to limit osteoclastogenesis and bone resorption via OPG was few.
Conclusions— The RANK–RANKL–OPG system is active in bone remodeling in dogs. In elbow dysplasia, a surplus of molecules promoting osteoclastogenesis was evident and is indicative of an imbalance between the mediators regulating bone resorption and bone formation. Both OPG and neutralizing antibodies against RANKL have the potential to counterbalance bone resorption.
Clinical Relevance— Therapeutic use of neutralizing antibodies against RANKL to inhibit osteoclast activation warrants further investigation. 相似文献
12.
Barger AM Fan TM de Lorimier LP Sprandel IT O'Dell-Anderson K 《Journal of veterinary internal medicine / American College of Veterinary Internal Medicine》2007,21(1):133-140
BACKGROUND: Receptor activator of nuclear factor kappa-B (RANK), RANK-ligand (RANKL), and the soluble decoy receptor osteoprotegerin (OPG) form a key axis modulating osteoclastogenesis. In health, RANKL-expressing bone stromal cells and osteoblasts activate osteoclasts through RANK ligation, resulting in homeostatic bone resorption. Skeletal tumors of dogs and cats, whether primary or metastatic, may express RANKL and directly induce malignant osteolysis. HYPOTHESIS: Bone malignancies of dogs and cats may express RANKL, thereby contributing to pathologic bone resorption and pain. Furthermore, relative RANKL expression in bone tumors may correlate with radiographic characteristics of bone pathology. ANIMALS: Forty-two dogs and 6 cats with spontaneously-occurring tumors involving bones or soft tissues were evaluated. METHODS: A polyclonal anti-human RANKL antibody was validated for use in canine and feline cells by flow cytometry and immunocytochemistry. Fifty cytologic specimens were collected from bone and soft tissue tumors of 48 tumor-bearing animals and assessed for RANKL expression. In 15 canine osteosarcoma (OSA) samples, relative RANKL expression was correlated with radiographic characteristics of bone pathology. RESULTS: Expression of RANKL by neoplastic cells was identified in 32/44 canine and 5/6 feline tumor samples. In 15 dogs with OSA, relative RANKL expression did not correlate with either radiographic osteolysis or bone mineral density as assessed by dual energy x-ray absorptiometry. CONCLUSIONS AND CLINICAL IMPORTANCE: In dogs and cats, tumors classically involving bone and causing pain, often may express RANKL. Confirming RANKL expression in tumors is a necessary step toward the rational institution of novel therapies targeting malignant osteolysis via RANKL antagonism. 相似文献
13.
The aim of this study was to determine whether receptor activator of nuclear factor NF-κB ligand (RANKL), osteoprotegerin (OPG) and a calcium:phosphorus (Ca:P) ratio of 2:1 could affect survival and activation of Muscovy duck osteoclasts (OCs). Bone marrow cells were obtained from 5-day-old Muscovy ducks and cultured with (Group A) No added factors, (B) 30 ng/mL soluble RANKL (sRANKL), (C) 30 ng/mL sRANKL and 10 ng/mL OPG, (D) 10 ng/mL OPG, (E) 50 ng/mL OPG, (F) 100 ng/mL OPG and (G) 30 ng/mL sRANKL, 6 mmol/L Ca and 3 mmol/L P.sRANKL promoted the survival of OCs on day 2, whereas the number of OCs decreased with addition of OPG in a dose-dependent manner. OPG and Ca:P (2:1) both inhibited OC survival induced by RANKL. RANKL stimulated bone resorption by OCs, whereas OPG, but not Ca:P (2:1), inhibited the activity of OCs induced by RANKL. RANKL promotes the survival and activation of OCs from Muscovy ducks, whereas OPG and, to a lesser extent, Ca:P (2:1) reduce the life span and inhibited the activation of OCs induced by RANKL. 相似文献
14.
Ying-Xiao Fu Jian-Hong Gu Yi-Ran Zhang Xi-Shuai Tong Hong-Yan Zhao Yan Yuan Xue-Zhong Liu Jian-Chun Bian Zong-Ping Liu 《Journal of veterinary science (Suw?n-si, Korea)》2013,14(4):405-412
The purpose of this study was to determine whether osteoprotegerin (OPG) could affect osteoclat differentiation and activation under serum-free conditions. Both duck embryo bone marrow cells and RAW264.7 cells were incubated with macrophage colony stimulatory factor (M-CSF) and receptor activator for nuclear factor κB ligand (RANKL) in serum-free medium to promote osteoclastogenesis. During cultivation, 0, 10, 20, 50, and 100 ng/mL OPG were added to various groups of cells. Osteoclast differentiation and activation were monitored via tartrate-resistant acid phosphatase (TRAP) staining, filamentous-actin rings analysis, and a bone resorption assay. Furthermore, the expression osteoclast-related genes, such as TRAP and receptor activator for nuclear factor κB (RANK), that was influenced by OPG in RAW264.7 cells was examined using real-time polymerase chain reaction. In summary, findings from the present study suggested that M-CSF with RANKL can promote osteoclast differentiation and activation, and enhance the expression of TRAP and RANK mRNA in osteoclasts. In contrast, OPG inhibited these activities under serum-free conditions. 相似文献
15.
骨是一个代谢活跃的器官,在整个生命周期中都在进行不断的更新与重建。在骨形态发生和重建的过程中主要受到细胞因子和激素的调节,同时骨代谢也受到OPG/RANKL/RANK系统的调控。论文主要对骨骼生理结构与骨组织细胞之间的关系,骨代谢和骨的形成过程,OPG/RANKL/RANK系统的生理功能,OPG/RANKL/RANK系统的影响因子以及骨代谢紊乱所引起的疾病几个方面作一综述。 相似文献